Shape CopyShapeLEARN MORE Group 4Rectangle 5 CopyFacebookRectangle 7 Copy 3Consulting IconPage 1Products IconTraining IconGroup 4Group 3Shape Copy 3Shape CopyIRETA-Logo-02Left ArrowRight ArrowLocationMenuSearchFacebookGoogle PlusLinkedInTwitterYoutube
Addiction Research, Education and Training | IRETA
MenuClose
Menu
  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Useful & Credible Sources
  • Case Studies
  • All Resources
  • Overview
  • Blog
  • Contact
  • Home
  • MyIRETA
Addiction Research, Education and Training | IRETA
  • Home
  • Who We Are
  • Blog
  • Contact
  • myIRETA
  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Useful & Credible Sources
  • Case Studies
  • All Resources
Resources

The Standard of Care in ALL Levels of Care: MAT Across the Continuum

Posted on March 2, 2020 by Jessica Williams

**Please note, we do not provide CEUs for viewing recorded webinars. If you are interested in receiving CEUs, you can view and register for our upcoming webinars here.**

Description

Medication-assisted treatment (MAT) for opioid use disorder should be available to patients regardless of their treatment setting, but most patients who are admitted to a residential level of care are not offered even one medication for OUD.

This webinar describes ways that patients in residential substance use treatment programs may be able to receive FDA-approved medications that are scientifically proven to save lives and promote recovery.

It outlines a) MAT basics, b) ways that outpatient MAT providers can partner with residential facilities and c) considerations for residential treatment providers in implementing MAT on-site.

Presenter

Zac Talbott, MSW is the Chief Clinical Officer of ReVIDA Recovery Centers, a Tennessee-based company that operates office-based opioid treatment programs across multiple states. He is the President of NAMA Recovery and President of the Alcohol and Drug Abuse Certification Board of Georgia. He also serves on the Executive Committee of the Board of Directors of the Opioid Treatment Providers of Georgia, which is the Georgia opioid treatment providers association and state chapter of the American Association for the Treatment of Opioid Dependence. In addition, Zac serves as a Planning Partner for the Substance Abuse and Mental Health Services Administration.

Zac has provided operational, policy, compliance, and clinical consulting for office-based opioid treatment providers and opioid treatment programs across six U.S. states, and is proficient in the behavioral health accreditation standards of The Joint Commission and CARF International.

Additional Resources

Slides

  • Type

  • Topics

  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
    • Training Resources
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Glossary
    • Useful & Credible Sources

611 William Penn Place, Suite 403 Pittsburgh, PA 15219 | P: 412-258-8565 | F: 412-391-2528
Terms & Conditions | Privacy Policy
© 2021 IRETA | Website by Imagebox.

Subscribe